Form 483 issued with 6 observations
Biocon announced that USFDA has completed a pre-approval inspection of its manufacturing facility in Malaysia and issued a Form 483 with 6 observations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
